Muller‐Vahl 2003/1.
Methods | Single centre, double blind, placebo controlled, parallel group 6 week study | |
Participants | 24 adult patients 19 male 5 female. Mean age 33 | |
Interventions | THC titrated to target dose10mg/day | |
Outcomes | Tic severity using Tourette syndrome Clinical Global Impressions scale; the Shapiro Tourette‐syndrome Severity Scale; the Yale Global Tic Severity Scale; a video protocol for assessment of tic intensity and frequency; and a patient self rating scale the Tourette Syndrome Symptom List. | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Low risk | A ‐ Adequate |